Cytocom, Inc. Reports Second Quarter 2021 Financial Results
Go back to Cytocom, Inc. Reports Second Quarter 2021 Financial Results| Cleveland Biolabs, Inc. (NASDAQ: CBLI) | Delayed: 3.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.17 | 52 Week High | $4.58 | |||
| Open | $156.00 | 52 Week Low | $1.45 | |||
| Day High | $3.17 | P/E | N/A | |||
| Day Low | $3.17 | EPS | $-0.49 | |||
| Volume | 30 | |||||
